Upcoming Webinar: FAIR Bioassay Annotation
CDD is a proud member of the Pistoia Alliance DataFAIRy BioAssay project. In 2020 a team of scientists from AstraZeneca, BMS, Novartis and Roche set forth to find a way to convert unstructured biological assay descriptions into FAIR information objects. CDD's BioHarmony technology was chosen to support the pilot project.
In this talk, the project team will present the lessons learned in the pilot project to annotate bioassay descriptions en masse and will chart a way to expand this effort in the future.
- Isabella Feierberg, Associate Principal Scientist, AstraZeneca
- Dana Vanderwall, Director of Biology & Preclinical IT, Bristol-Myers Squibb
- Rama Balakrishnan, Biomedical Ontology Specialist, Genentech
- Martin Romacker, Senior Principal Scientist in Scientific Solution Engineering and Architecture, Roche
- Samantha Jeschonek, Research Scientist, Collaborative Drug Discovery
- Timothy Ikeda, Automation Principal Scientist, AstraZeneca
- Gabriel Backiananthan, Novartis
- Anosha Siripala, Technical Associate Director, Scientific Products, Novartis Institutes for BioMedical Research (NIBR)
Other posts you might be interested in
View All Posts
CDD Vault Updates
2 min
July 24, 2025
CDD Vault Update (July #2 2025) Search Inventory by Molecule & Batch Fields, Protocol Plate Locations, Stoichiometry Table Debiting, Synonym Links in ELN, Chemical Properties in Structure Editor
Read More
CDD Blog
5 min
July 22, 2025
Drug Discovery Industry Roundup with Barry Bunin — July 22, 2025
Read More
Events
4 min
July 17, 2025
Recap Of The Collaborative Drug Discovery's Inaugural Canadian User Group Meeting
Read More